Why BP Is One of the Best Oil Stocks to Buy Right Now

BP generated Q2 operating cash flow of $10.86 billion, up 73% year over year, while underlying replacement-cost profit more than doubled to $5.73 billion and net debt declined to $22.25 billion. Brent crude's move above $100 per barrel provides an additional cash-flow tailwind, while BP raised its quarterly dividend more than 4% to $0.52 per share. Consensus 2026 EPS is projected to rise more than 123% to $6.45, with estimates up nearly 30% over 60 days; BP trades at about 7x forward earnings versus roughly 12x for Chevron and Exxon.

Analysis

The apparent BP discount is not automatically a mispricing: its lower multiple versus XOM/CVX reflects a higher perceived cost of capital from a less consistent capital-return framework, a more complex refining/trading mix, and residual execution risk around portfolio repositioning. The relevant rerating catalyst is therefore not another upward oil tick, but evidence over the next 1-3 quarters that incremental upstream cash flow is being converted into buybacks, lower net debt, and project delivery rather than absorbed by capex or lower-return transition spending. If management demonstrates this discipline, even partial closure of the valuation gap could add materially to commodity-driven earnings upside.

BP is likely more operationally geared to a sustained price-and-margin environment than the U.S. majors, but that cuts both ways. A $100+ Brent price sustained for only weeks may lift headline estimates without changing normalized valuation; three consecutive months of tight physical balances and resilient refining margins would be needed to support 2026-27 consensus revisions and a multiple rerating. The key second-order risk is that higher crude feeds inflation, strengthens the dollar, and eventually compresses refined-product demand—conditions under which integrated majors' downstream segments can cease to offset upstream volatility.

Consensus is also likely overstating the precision of the quoted forward P/E comparison. Earnings estimates for commodity producers embed price decks, trading gains, tax rates, and non-cash items that differ materially across BP, XOM, and CVX. BP's opportunity is best framed as a cash-return execution trade rather than a simple "cheapest oil major" trade; it should outperform if crude remains firm while capital allocation improves, but it can underperform XOM/CVX in a crude reversal because its discount may widen rather than cushion the drawdown.

Key Decisions for Investors

• Initiate a 3-6 month long BP / short XOM pair, sized beta-neutral, only if Brent holds above $95 for 10 trading sessions. Thesis is BP-specific estimate revisions plus a 1-2 turn EV/FCF discount compression; target 10-15% relative return. Exit if Brent falls below $85 or BP does not reaffirm buyback and net-debt objectives at the next results.
• For directional energy exposure, prefer a staged BP long rather than chasing spot oil: buy one-third now, add on confirmation of quarterly operating cash flow and capital-return guidance, and reserve final sizing for any oil-driven pullback. A 6-18 month target requires project start-ups to meet schedule and cash conversion to exceed capex growth; missed production guidance or a material capex increase falsifies the thesis.
• Use XLE puts or short Brent exposure as a portfolio hedge against the primary macro risk rather than reducing the BP position immediately. The hedge becomes more valuable if U.S. dollar strength and weakening refinery margins emerge together; unwind it if physical inventory draws persist and product cracks remain elevated.
• Do not act on NNOX from this item; its inclusion is promotional and has no identifiable economic linkage to the energy thesis.